Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023-Reference-Cited by-同舟云学术

Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023

Published:2024-05-22 Issue:8 Volume:15 Page:1717-1733
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Xiong Si,Gou Ruoyu,Liang Xudong,Wu Hao,Qin Shuitao,Li Bing,Luo Changjun^ORCID,Chen Junan

Funder

the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13300-024-01594-7.pdf

Reference32 articles.

1. Yan J, et al. Obesity- and aging-induced excess of central transforming growth factor-β potentiates diabetic development via an RNA stress response. Nat Med. 2014;20:1001–8.

2. A 16-year prospective cohort study to evaluate effects of long-term fluctuations in obesity indices of prediabetics on the incidence of future diabetes - PubMed. https://pubmed.ncbi.nlm.nih.gov/34079024/. Accessed 3 Mar 2024.

3. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk. J Am Coll Cardiol. 2022;80:2361–71.

4. Hess DA, et al. Vascular repair and regeneration in cardiometabolic diseases. Eur Heart J. 2022;43:450–9.

5. Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review - PubMed. https://pubmed.ncbi.nlm.nih.gov/32029136/. Accessed 3 Mar 2024.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-Glucan-based superabsorbent hydrogel acts as a gastrointestinal exoskeleton enhancing satiety and interfering fat hydrolysis;International Journal of Biological Macromolecules;2024-08

2. Semaglutide-related ADEs identified in FAERS;Reactions Weekly;2024-06-08